BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35212073)

  • 1. Association between Helicobacter pylori antibodies determined by multiplex serology and gastric cancer risk: A meta-analysis.
    El Hafa F; Wang T; Ndifor VM; Jin G
    Helicobacter; 2022 Jun; 27(3):e12881. PubMed ID: 35212073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis.
    Yao P; Kartsonaki C; Butt J; Jeske R; de Martel C; Plummer M; Guo Y; Clark S; Walters RG; Chen Y; Avery D; Lv J; Yu C; Wang H; Hill M; Peto R; Li L; Waterboer T; Chen Z; Millwood IY; Yang L
    Int J Epidemiol; 2023 Aug; 52(4):1197-1208. PubMed ID: 36913255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
    Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
    Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
    Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.
    Shakeri R; Malekzadeh R; Nasrollahzadeh D; Pawlita M; Murphy G; Islami F; Sotoudeh M; Michel A; Etemadi A; Waterboer T; Poustchi H; Brennan P; Boffetta P; Dawsey SM; Kamangar F; Abnet CC
    Cancer Res; 2015 Nov; 75(22):4876-83. PubMed ID: 26383162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.
    Gao L; Michel A; Weck MN; Arndt V; Pawlita M; Brenner H
    Cancer Res; 2009 Aug; 69(15):6164-70. PubMed ID: 19602590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
    Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardia and non-cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta-analysis, and estimation of population attributable fraction.
    Han Z; Liu J; Zhang W; Kong Q; Wan M; Lin M; Lin B; Ding Y; Duan M; Li Y; Zuo X; Li Y
    Helicobacter; 2023 Apr; 28(2):e12950. PubMed ID: 36645649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
    Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
    J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
    Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of gastric cancer in association with Helicobacter pylori different virulence factors: A systematic review and meta-analysis.
    Pormohammad A; Ghotaslou R; Leylabadlo HE; Nasiri MJ; Dabiri H; Hashemi A
    Microb Pathog; 2018 May; 118():214-219. PubMed ID: 29510208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of gastric cancer, HLA-DQA1, and infection with Helicobacter pylori CagA+ and VacA+ in a Mexican population.
    Garza-González E; Bosques-Padilla FJ; Pérez-Pérez GI; Flores-Gutiérrez JP; Tijerina-Menchaca R
    J Gastroenterol; 2004 Dec; 39(12):1138-42. PubMed ID: 15622476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
    Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
    Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis on the relative and attributable risk of
    Gu J; He F; Clifford GM; Li M; Fan Z; Li X; Wang S; Wei W
    Expert Rev Mol Diagn; 2023; 23(12):1251-1261. PubMed ID: 37905778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
    Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
    Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Song L; Song M; Rabkin CS; Williams S; Chung Y; Van Duine J; Liao LM; Karthikeyan K; Gao W; Park JG; Tang Y; Lissowska J; Qiu J; LaBaer J; Camargo MC
    J Proteome Res; 2021 Jan; 20(1):409-419. PubMed ID: 33108201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
    Kokkola A; Louhimo J; Puolakkainen P; Alfthan H; Haglund C; Rautelin H
    World J Gastroenterol; 2005 Feb; 11(7):1032-6. PubMed ID: 15742409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.